$16.00
Manufacturer: Ukraine
* Infectious and toxic liver diseases (viral hepatitis A and B, toxic hepatitis, cirrhosis of the liver, hepatocholecystitis); * kidney diseases, especially with the development of chronic kidney failure (glomerulonephritis, pyelonephritis, polycystic kidney disease, etc.); * cholestasis of various origins, including the addition of allergic reactions and liver failure; * diseases of the gastrointestinal tract (enterocolitis, gastritis, colitis, diarrhea, post-resection syndrome, stomach and duodenal ulcer, etc.); * food and drug allergies infectious-allergic and atopic bronchial asthma, atopic dermatitis, urticaria eczema, etc.);
Description
LAKTOBIO COMPOSITION
active substance: 100 g of paste contains methylsilicic acid hydrogel 70 g auxiliary substances: purified water.
LAKTOBIO DOSAGE FORM
Paste for oral administration.
LAKTOBIO BASIC PHYSICAL AND CHEMICAL PROPERTIES
homogeneous pasty mass of white color, odorless.
LAKTOBIO PHARMACOLOGICAL GROUP
Enterosorbents. ATC code A07B C. Pharmacological properties Pharmacological.
INDICATIONS
As part of complex detoxification therapy for chronic renal failure with toxic hepatitis, viral hepatitis A, B, cirrhosis of the liver and cholestasis of various etiologies with enterocolitis, colitis, diarrhea, gastritis with low acidity, with alcohol and drug poisoning; with allergic and skin diseases (diathesis, neurodermatitis) with burn intoxication; purulent-septic and inflammatory processes, accompanied by intoxication; toxicosis of the first half of pregnancy, in the complex therapy of intestinal dysbiosis.
CONTRAINDICATIONS
Acute intestinal obstruction.
INTERACTION WITH OTHER DRUGS AND OTHER KINDS OF INTERACTIONS
The drug may reduce the effect of other drugs that are used with it. Concomitant use with drugs belonging to the class of bile acid sequestrants, such as cholestyramine, is not recommended due to the increased likelihood of constipation. The drug should not be used in conjunction with silver preparations.
FEATURES OF APPLICATION
Subject to the method of application (Enterosgel and drugs are taken at intervals of 1.5-2 hours), the drug can be used in complex therapy with other drugs and prophylactic agents, including prebiotics and probiotics (bifidum-, lactobacilli), phytopreparations, adaptogens, immunomodulators.
DOSAGE AND METHOD OF APPLICATION
Take orally 3 times a day, 1.5-2 hours before or 2:00 after meals or medication, drinking plenty of water. For adults and children over 14 years old, a single dose is 15 g (a tablespoon), a daily dose is 45 g. For children from birth to 5 years, a single dose is 5 g (a teaspoon), a daily dose is 15 g; from 5 to 14 years old single dose – 10 g (dessert spoon), daily dose – 30 g. The course of treatment – from 7 to 14 days. In severe forms of the disease, a double single dose can be used during the first three days, and in the chronic course of the disease (chronic renal failure), a longer (up to 1 month) use of the drug is possible.
Recent Reviews